VAXART INC (VXRT) Stock Fundamental Analysis

NASDAQ:VXRT • US92243A2006

0.32 USD
-0.11 (-25.06%)
At close: Jul 7, 2025
0.3251 USD
+0.01 (+1.59%)
After Hours: 7/7/2025, 10:34:23 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Taking everything into account, VXRT scores 2 out of 10 in our fundamental rating. VXRT was compared to 523 industry peers in the Biotechnology industry. VXRT may be in some trouble as it scores bad on both profitability and health. VXRT shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year VXRT has reported negative net income.
  • In the past year VXRT has reported a negative cash flow from operations.
  • VXRT had negative earnings in each of the past 5 years.
  • In the past 5 years VXRT always reported negative operating cash flow.
VXRT Yearly Net Income VS EBIT VS OCF VS FCFVXRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

  • VXRT has a Return On Assets (-36.66%) which is comparable to the rest of the industry.
  • The Return On Equity of VXRT (-127.41%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -36.66%
ROE -127.41%
ROIC N/A
ROA(3y)-66.71%
ROA(5y)-50.62%
ROE(3y)-117.91%
ROE(5y)-83.49%
ROIC(3y)N/A
ROIC(5y)N/A
VXRT Yearly ROA, ROE, ROICVXRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for VXRT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VXRT Yearly Profit, Operating, Gross MarginsVXRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K -100K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • VXRT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for VXRT has been increased compared to 1 year ago.
  • The number of shares outstanding for VXRT has been increased compared to 5 years ago.
  • The debt/assets ratio for VXRT has been reduced compared to a year ago.
VXRT Yearly Shares OutstandingVXRT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
VXRT Yearly Total Debt VS Total AssetsVXRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • VXRT has an Altman-Z score of -5.12. This is a bad value and indicates that VXRT is not financially healthy and even has some risk of bankruptcy.
  • VXRT's Altman-Z score of -5.12 is on the low side compared to the rest of the industry. VXRT is outperformed by 60.04% of its industry peers.
  • VXRT has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • VXRT has a Debt to Equity ratio (0.01) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -5.12
ROIC/WACCN/A
WACC9.59%
VXRT Yearly LT Debt VS Equity VS FCFVXRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M 150M

2.3 Liquidity

  • A Current Ratio of 0.64 indicates that VXRT may have some problems paying its short term obligations.
  • VXRT has a Current ratio of 0.64. This is amonst the worse of the industry: VXRT underperforms 91.22% of its industry peers.
  • VXRT has a Quick Ratio of 0.64. This is a bad value and indicates that VXRT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • VXRT's Quick ratio of 0.64 is on the low side compared to the rest of the industry. VXRT is outperformed by 90.68% of its industry peers.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.64
VXRT Yearly Current Assets VS Current LiabilitesVXRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • VXRT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.06%, which is quite impressive.
  • VXRT shows a strong growth in Revenue. In the last year, the Revenue has grown by 433.37%.
  • The Revenue has been growing by 23.72% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)49.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)433.37%
Revenue growth 3Y217.11%
Revenue growth 5Y23.72%
Sales Q2Q%857.18%

3.2 Future

  • The Earnings Per Share is expected to grow by 0.50% on average over the next years.
  • Based on estimates for the next years, VXRT will show a very strong growth in Revenue. The Revenue will grow by 30.95% on average per year.
EPS Next Y15.8%
EPS Next 2Y-6.58%
EPS Next 3Y-9.17%
EPS Next 5Y0.5%
Revenue Next Year-37.03%
Revenue Next 2Y-48.87%
Revenue Next 3Y-34.32%
Revenue Next 5Y30.95%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VXRT Yearly Revenue VS EstimatesVXRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M 200M 250M
VXRT Yearly EPS VS EstimatesVXRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • VXRT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VXRT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VXRT Price Earnings VS Forward Price EarningsVXRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VXRT Per share dataVXRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2 -0.3

4.3 Compensation for Growth

  • VXRT's earnings are expected to decrease with -9.17% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.58%
EPS Next 3Y-9.17%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • VXRT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

VAXART INC

NASDAQ:VXRT (7/7/2025, 10:34:23 PM)

After market: 0.3251 +0.01 (+1.59%)

0.32

-0.11 (-25.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)05-13
Earnings (Next)08-07
Inst Owners12.07%
Inst Owner Change-1.54%
Ins Owners1.03%
Ins Owner Change3.06%
Market Cap73.03M
Revenue(TTM)47.40M
Net Income(TTM)-58.12M
Analysts86.67
Price Target3.06 (856.25%)
Short Float %1.6%
Short Ratio0.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)41.06%
Min EPS beat(2)31.15%
Max EPS beat(2)50.98%
EPS beat(4)3
Avg EPS beat(4)-26.88%
Min EPS beat(4)-230.84%
Max EPS beat(4)50.98%
EPS beat(8)7
Avg EPS beat(8)-4.36%
EPS beat(12)10
Avg EPS beat(12)-1.05%
EPS beat(16)13
Avg EPS beat(16)-0.9%
Revenue beat(2)1
Avg Revenue beat(2)43%
Min Revenue beat(2)-28.31%
Max Revenue beat(2)114.31%
Revenue beat(4)3
Avg Revenue beat(4)1682.62%
Min Revenue beat(4)-28.31%
Max Revenue beat(4)6175.49%
Revenue beat(8)7
Avg Revenue beat(8)1313.72%
Revenue beat(12)7
Avg Revenue beat(12)849.62%
Revenue beat(16)7
Avg Revenue beat(16)625.02%
PT rev (1m)-35.71%
PT rev (3m)-35.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.83%
EPS NY rev (1m)0%
EPS NY rev (3m)9.95%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)-82.09%
Revenue NY rev (1m)38.91%
Revenue NY rev (3m)323.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.54
P/FCF N/A
P/OCF N/A
P/B 1.6
P/tB 1.94
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.39
Fwd EYN/A
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0.21
BVpS0.2
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -36.66%
ROE -127.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-66.71%
ROA(5y)-50.62%
ROE(3y)-117.91%
ROE(5y)-83.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.2%
Cap/Sales 1.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.64
Quick Ratio 0.64
Altman-Z -5.12
F-Score5
WACC9.59%
ROIC/WACCN/A
Cap/Depr(3y)64.4%
Cap/Depr(5y)72.15%
Cap/Sales(3y)3209.1%
Cap/Sales(5y)2046.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y15.8%
EPS Next 2Y-6.58%
EPS Next 3Y-9.17%
EPS Next 5Y0.5%
Revenue 1Y (TTM)433.37%
Revenue growth 3Y217.11%
Revenue growth 5Y23.72%
Sales Q2Q%857.18%
Revenue Next Year-37.03%
Revenue Next 2Y-48.87%
Revenue Next 3Y-34.32%
Revenue Next 5Y30.95%
EBIT growth 1Y30.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y67.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y64.76%
OCF growth 3YN/A
OCF growth 5YN/A

VAXART INC / VXRT FAQ

Can you provide the ChartMill fundamental rating for VAXART INC?

ChartMill assigns a fundamental rating of 2 / 10 to VXRT.


What is the valuation status for VXRT stock?

ChartMill assigns a valuation rating of 0 / 10 to VAXART INC (VXRT). This can be considered as Overvalued.


What is the profitability of VXRT stock?

VAXART INC (VXRT) has a profitability rating of 1 / 10.


How financially healthy is VAXART INC?

The financial health rating of VAXART INC (VXRT) is 1 / 10.


Can you provide the expected EPS growth for VXRT stock?

The Earnings per Share (EPS) of VAXART INC (VXRT) is expected to grow by 15.8% in the next year.